{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:24:00Z","timestamp":1776662640116,"version":"3.51.2"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670581"],"award-info":[{"award-number":["81670581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Committee","doi-asserted-by":"crossref","award":["17441901000"],"award-info":[{"award-number":["17441901000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Collaborative Innovation Center for Translational Medicine","award":["TM201804"],"award-info":[{"award-number":["TM201804"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To investigate the clinicopathological characteristics and relevant prognostic factors of gastro-entero-pancreatic neuroendocrine neoplasm (GEP-NEN), to improve our understanding of GEP-NEN.<\/jats:p>\n            <jats:p>This was a retrospective analysis of 155 patients (average age 53.7\u200a\u00b1\u200a13.6 years) pathologically diagnosed with GEP-NEN. We analyzed the clinicopathological characteristics, treatment, and prognostic factors of GEP-NEN.<\/jats:p>\n            <jats:p>The most common primary site was the pancreas (41.9%), followed by the rectum, stomach and duodenum. Most cases were nonfunctional GEP-NENs (149\/155) with nonspecific symptoms. TNM stage and histological grade were determined by the latest criteria. Surgical resection was the mainstay of treatment in 150 patients, and 22 patients received chemotherapy under different circumstances. A total of 130 patients were followed up for a median of 44 months, and 1-year and 3-year survival rates were 82.3% and 72.3%, respectively. According to univariate and multivariate analysis, incidental diagnosis, maximum tumor diameter, tumor stage, lymph node and distant metastasis, TNM stage, and histological grade were significantly correlated with overall survival, but histological grade was the only factor confirmed as an independent prognostic factor for long-term survival of GEP-NEN.<\/jats:p>\n            <jats:p>GEP-NEN, with an increasing trend in incidence, occurred most frequently in the pancreas. Nonfunctional tumors with nonspecific symptoms comprised the majority of cases. The main treatment was surgical resection. Histological grade was confirmed as the only independent prognostic factor.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021682","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T06:12:17Z","timestamp":1597299137000},"page":"e21682","source":"Crossref","is-referenced-by-count":8,"title":["An 11-year retrospective study: clinicopathological and survival analysis of gastro-entero-pancreatic neuroendocrine neoplasm"],"prefix":"10.1097","volume":"99","author":[{"given":"Hua","family":"Liu","sequence":"first","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"},{"name":"Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiao Tong University, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongli","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"},{"name":"Department of Surgery, Luwan Branch, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaige","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Luwan Branch, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Surgery, Luwan Branch, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xujie","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Surgery, Luwan Branch, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongjie","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Luwan Branch, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Luwan Branch, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital\/Lu Wan Branch, Shanghai Jiao Tong University, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"e62487","DOI":"10.1371\/journal.pone.0062487","article-title":"The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer"},{"key":"R6-20230915","first-page":"276","article-title":"Current status of clinical research on gastroenteropancreatic neuroendorine tumors in China. (In Chinese)","volume":"17","author":"Linjie","year":"2017","journal-title":"Chin J Gastroenterol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.3748\/wjg.14.5377","article-title":"Neuroendocrine tumors of the gastro-entero-pancreatic system","volume":"14","author":"Massironi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/ajco.12121","article-title":"Single institutional series of neuroendocrine tumors managed in the Australian Capital Territory","volume":"12","author":"Malik","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12902-016-0087-9","article-title":"Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis","volume":"16","author":"Chan","year":"2016","journal-title":"BMC Endocr Disord BioMed Central"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00535-009-0194-8","article-title":"Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan","volume":"45","author":"Ito","year":"2010","journal-title":"J Gastroenterol"},{"key":"R11-20230915","first-page":"258","article-title":"Clinicopathological features and survival analysis of gastroenteropancreatic neuroendocrine neoplasms: a retrospective study in a single center of China","volume":"27","author":"Jiao","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1472-6823-12-30","article-title":"Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: a single-institution analysis (1995\u20132012) in South China","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MPA.0000000000000586","article-title":"Prognostic validity of the American Joint Committee on cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: a retrospective nationwide multicenter study in South Korea","volume":"45","author":"Cho","year":"2016","journal-title":"Pancreas"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000369818","article-title":"Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution","volume":"100","author":"Massironi","year":"2014","journal-title":"Neuroendocrinology"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1751-2980.12239","article-title":"Application of AJCC\/UICC and WHO-2010 classifications for GEP-NEN in Chinese patients","volume":"16","author":"Ye","year":"2015","journal-title":"J Dig Dis"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"9856140","DOI":"10.1155\/2017\/9856140","article-title":"Advances and current concepts in the medical management of gastroenteropancreatic neuroendocrine neoplasms","volume":"2017","author":"Alexandraki","year":"2017","journal-title":"Biomed Res Int"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1530\/ERC-16-0151","article-title":"Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future","volume":"23","author":"Oberg","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","article-title":"Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)","volume":"21","author":"Garcia-Carbonero","year":"2010","journal-title":"Ann Oncol"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/j.gastro.2007.01.006","article-title":"Survival from malignant digestive endocrine tumors in England and Wales: a population-based study","volume":"132","author":"Lepage","year":"2007","journal-title":"Gastroenterology"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/gutjnl-2018-317233","article-title":"Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system","volume":"69","author":"Hong","year":"2020","journal-title":"Gut"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1078-0432.CCR-17-1921","article-title":"Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome","volume":"24","author":"Derks","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","journal-title":"Clin Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:15:58Z","timestamp":1694826958000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":25,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021682","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}